The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 21, 2025
Filed:
Jul. 28, 2021
Amgen Inc., Thousand Oaks, CA (US);
Scott R. Gibson, Simi Valley, CA (US);
Sheldon B. Moberg, Thousand Oaks, CA (US);
Basel Hasan Taha, Thousand Oaks, CA (US);
Margaux Frances Boyaval, Newbury Park, CA (US);
Mark A. Destefano, Collegeville, PA (US);
Lawton Laurence, Phoenixville, PA (US);
John C. Love, San Diego, CA (US);
Ian B. Hanson, Wayne, PA (US);
Paul F. Bente, IV, Wayne, PA (US);
Matthew J. Clemente, Carmel, IN (US);
Antonio Ubach, Tucson, AZ (US);
Rajan Ramaswamy, San Diego, CA (US);
Daniel S. Codd, Escondido, CA (US);
Scott Beaver, San Marcos, CA (US);
Kevin L. Bokelman, San Diego, CA (US);
Ian P. Dardani, Radnor, PA (US);
Sean M. O'connor, West Chester, PA (US);
Danielle Feldman, Philadelphia, PA (US);
AMGEN INC., Thousand Oaks, CA (US);
Abstract
Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device may include a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector may define a sterile fluid flowpath between the container and the insertion mechanism. Optionally, a cannula initially disposed about the needle may be included. The cannula may be retained in the patient at an injection site created by the needle after the needle is withdrawn from the patient. Methods of assembly and operation are also provided.